Associated Papers
Molecular profiling of soft-tissue sarcomas with FoundationOne® Heme identifies potential targets for sarcoma therapy: a single-centre experience.
Scheipl S et al.
Therapeutic Advances in Medical Oncology, 2021
34367342 (PubMed )
Supplement: sj-xlsx-1-tam-10.1177_17588359211029125.xlsx › FMI_Archer
Role of germline aberrations affecting CTNNA1, MAP3K6 and MYD88 in gastric cancer susceptibility.
Weren RDA et al.
Journal of Medical Genetics, 2018
Genetic predisposition to gastric cancer.
Petrovchich I et al.
Seminars in Oncology, 2016
Hereditary diffuse gastric cancer: What the clinician should know.
Tan RY et al.
World Journal of Gastrointestinal Oncology, 2015
Germline mutations in MAP3K6 are associated with familial gastric cancer.
Gaston D et al.
Plos Genetics, 2014
Select a paper to view details